Ledger.Open graph →
SEC Form D · filed September 9, 2025

Immuneering Corp

Offering
$25.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Benjamin J. Zeskind · Cambridge, MAExec · DirectorRobert J. Carpenter · Cambridge, MADirectorPeter J. Feinberg · Dallas, TXDirectorJeremy Uzan · Paris, I0DirectorRaffi Kamber · Paris, I0Exec · DirectorLaurie B. Keating · Cambridge, MADirectorThomas J. Schall · Cambridge, MADirectorDiana F. Hausman · Cambridge, MADirectorMercator Management (USA) LP · PRINCETON, NJExec · DirectorWarrayure LLC · PRINCETON, NJDirectorLaurie B. Keating · Cambridge, MADirectorThomas J. Schall · Cambridge, MADirectorDiana F. Hausman · Cambridge, MADirectorPeter J. Feinberg · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗